JFGFX
Price
$12.31
Change
-$0.34 (-2.69%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

JFGFX vs RWIBX

Header iconJFGFX vs RWIBX Comparison
Open Charts JFGFX vs RWIBXBanner chart's image
JHancock Fundamental Global Franchise R6
Price$12.31
Change-$0.34 (-2.69%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
JFGFX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFGFX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFGFX is a StrongBuy and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. JFGFX (243M). RWIBX pays higher dividends than JFGFX: RWIBX (1.05) vs JFGFX (0.55). JFGFX was incepted earlier than RWIBX: JFGFX (8 years) vs RWIBX (23 years). JFGFX is a more actively managed with annual turnover of: 31.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than JFGFX: RWIBX (250) vs JFGFX (1000000). RWIBX annual gain was more profitable for investors over the last year : 11.34 vs. JFGFX (7.65). RWIBX return over 5 years is better than : 29.64 vs. JFGFX (9.17).
JFGFXRWIBXJFGFX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD13.3519.781137%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets243M121B0%
Annual Yield % from dividends0.551.0552%
Returns for 1 year7.6511.3467%
Returns for 3 years-3.898.41-46%
Returns for 5 years9.1729.6431%
Returns for 10 yearsN/A44.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics